Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients

Controlled, Randomized, Parallel Group Study to Assess Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients

The study will evaluate kidney graft function in maintenance renal transplant patients.

Inclusion criteria:

• Male or female recipients of single or double renal transplant performed since at least one year and no more that 5 years
• Age > 18 yrs
• Adequate and stable renal function
• Informed consent.

Exclusion criteria:

• Kidney transplant combined with other organs;
• Significant proteinuria
• Severe ongoing infections;
• Present or historical malignant neoplasia, of any type, with the exception of excised non metastatic non-melanoma skin cancer and previous malignant neoplasia cured since at least 5 years;
• Relapse of the end-stage renal disease on the transplanted kidney;
• Leucopenia, thrombocytopenia or severe anemia;

Other protocol-defined inclusion/exclusion criteria may apply